Sputum periostin in patients with different severe asthma phenotypes. - Wikidata - wikimedia - TriplyDB

Sputum periostin in patients with different severe asthma phenotypes.

Sputum periostin in patients with different severe asthma phenotypes.

http://www.wikidata.org/entity/Q51663505

about

Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma Biomarkers and severe asthma: a critical appraisal Periostin: its role in asthma and its potential as a diagnostic or therapeutic target Using Periostin as a Biomarker in the Treatment of Asthma Immune signatures of pathogenesis in the peritoneal compartment during early infection of sheep with Fasciola hepatica Current and future biomarkers in allergic asthma.Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma.Periostin in Exhaled Breath Condensate and in Serum of Asthmatic Patients: Relationship to Upper and Lower Airway Disease.Treatment of severe asthma: entering the era of targeted therapy.Obesity's effect on asthma extends to diagnostic criteria.CD26 and Asthma: a Comprehensive Review.Asthma biomarkers in the age of biologics.Airway pathology in severe asthma is related to airflow obstruction but not symptom control.Periostin in inflammation and allergy.Severe bronchial asthma in children: a review of novel biomarkers used as predictors of the disease.Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD.Sputum periostin in patients with different severe asthma phenotypes.A Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma Non-eosinophilic asthma: current perspectives

P2860

Q26779940-B98BB964-3056-4748-A976-F6FF25F12F4C Q26782718-EE8EEB32-89D1-43B7-859F-5BF181C31CE6 Q27021972-858857C9-4DA1-4080-9CDE-A76FD9834C24 Q28067637-FB3EF58F-D22E-42AC-B714-AB3F9B76ED0F Q33765735-7E65D5A8-0B4B-49B6-8945-9EBE6DF6A10A Q35878914-D37CA851-7899-48DA-9783-D4637D054C6F Q36128008-04269642-C65D-487E-A9CC-40047D806302 Q37606288-04D32A7D-ACA1-485E-98D6-C8E5DAD8C456 Q38578918-F978E638-423D-4D16-9A13-B1F3A59E310E Q38721003-7A265175-CADB-47DE-9F0C-8657F4C80FBF Q38937243-6431176D-832F-4CC7-83B7-6981FC30FE00 Q47169950-EFD5A269-95F4-46AC-8E5C-867976711859 Q47727484-BFA8C466-445F-4FD1-972A-4AB589131468 Q47830641-A38417B8-51F9-4295-A8FE-9B65D2A74442 Q49201946-382C151D-029B-4E2A-BCBB-479C7A1AF067 Q51442234-E9210E46-074A-4D7C-9DB9-3F0F1443031A Q51621143-11182FC6-7FB1-4F7E-95E6-A427FE947D94 Q58699971-5BD5BA7D-D6EF-4AC2-8935-6ACBC443FEC5 Q59135356-60DFEFCB-BB75-4330-85ED-D933861D2CC8

P2860

Sputum periostin in patients with different severe asthma phenotypes.

http://www.wikidata.org/entity/Q51663505

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Sputum periostin in patients with different severe asthma phenotypes.

@en

Sputum periostin in patients with different severe asthma phenotypes.

@nl

type

label

Sputum periostin in patients with different severe asthma phenotypes.

@en

Sputum periostin in patients with different severe asthma phenotypes.

@nl

prefLabel

Sputum periostin in patients with different severe asthma phenotypes.

@en

Sputum periostin in patients with different severe asthma phenotypes.

@nl

P1433

Q51663505-BE32B915-882C-4718-86E5-5670C4EF18F1

P1476

Q51663505-C7CE7968-261C-411A-BA5E-F41051E4AB64

P2093

Q51663505-0534D8E0-DA2E-4F2C-BD21-E5F7ED808978

Q51663505-08316439-98D8-4E7E-9BC5-D91FA583BF68

Q51663505-249CEDD0-4BE9-42A4-B97B-30D4C4D3A907

Q51663505-271694E7-51E6-4A51-83A9-F6E6FAD1C963

Q51663505-5BBDA311-6714-4BC5-A973-EA8F294E5E59

Q51663505-714B423C-0565-4554-93E9-4F8753A4AD0F

Q51663505-A90C7D0B-45EB-48F4-87D2-7A5612DA9ED9

Q51663505-CC238072-8AA8-40BF-ACA9-F2571DA86847

Q51663505-E74A4FEB-9535-4331-A7B4-CB625C2927B2

P2860

Q51663505-1F7EA1F3-5BB8-4C90-9C92-A1EFAEEB7207

Q51663505-2734A272-CC50-4241-9546-6FC1B7A9CD00

Q51663505-37003142-39B3-4556-B0BD-F5475CBE2949

Q51663505-469B9140-AB58-46DE-AA63-D18491CC779F

Q51663505-4A5EF1D9-A127-44C4-95D5-6B32B4AFB424

Q51663505-51D644D8-2027-436E-B18F-3BF961B9941A

Q51663505-57D920B7-10E3-4318-BCB3-086180EA8046

Q51663505-5D630DC8-86FA-400C-B532-758D3290D695

Q51663505-5FBC87C4-2C1A-4EC9-8504-B4410803404D

Q51663505-61CAFE95-8940-4D51-93FD-336B22ABA5BB

P304

Q51663505-B3EC45F7-427E-4ABF-BAC3-09F3DC8ADD64

P31

Q51663505-485BA9D4-48FE-45C8-9BFD-E3D698A1DF78

P356

Q51663505-74B6DF28-DC9D-4364-83E5-49178F837492

P433

Q51663505-DF2BC2D5-097B-41C0-BCD5-F7AFE759237B

P478

Q51663505-505D82D8-F057-477F-97B3-EBD8502741B2

P577

Q51663505-5F991B9C-F589-4BFB-A62F-CFB241A3313D

P698

Q51663505-6833A735-1A10-4CE2-B97C-C7A707D68420

P921

Q51663505-7263F0A7-62B0-4E34-BA49-2A149E5173B9

Q51663505-FCA3ECEC-184A-4E26-889D-88D93B5B6D6B

P356

P1433

P1476

Sputum periostin in patients with different severe asthma phenotypes.

@en

P2093

C Villasante

http://www.w3.org/2001/XMLSchema#string

D Romero

http://www.w3.org/2001/XMLSchema#string

I Bobolea

http://www.w3.org/2001/XMLSchema#string

J Canabal

http://www.w3.org/2001/XMLSchema#string

P Barranco

http://www.w3.org/2001/XMLSchema#string

S Quirce

http://www.w3.org/2001/XMLSchema#string

V Del Pozo

http://www.w3.org/2001/XMLSchema#string

V López-Carrasco

http://www.w3.org/2001/XMLSchema#string

V Sanz

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I

Standardization of Spirometry, 1994 Update. American Thoracic Society

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes

Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI).

Lebrikizumab treatment in adults with asthma.

Severe asthma: lessons from the Severe Asthma Research Program.

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.

T-helper type 2-driven inflammation defines major subphenotypes of asthma.

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

P304

540-546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.12580

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25631525

http://www.w3.org/2001/XMLSchema#string

P921